| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.933 | 11.519 | 38.258 | 49.025 | 57.666 | 26.744 | 23.489 | 7.888 | 22.045 | 37.025 |
| Total Income - EUR | 7.933 | 11.519 | 38.258 | 49.025 | 57.666 | 28.180 | 23.489 | 7.888 | 23.820 | 37.025 |
| Total Expenses - EUR | 7.298 | 10.163 | 18.213 | 28.207 | 33.364 | 26.281 | 16.907 | 12.709 | 8.663 | 8.349 |
| Gross Profit/Loss - EUR | 635 | 1.356 | 20.045 | 20.819 | 24.302 | 1.899 | 6.582 | -4.821 | 15.157 | 28.677 |
| Net Profit/Loss - EUR | 397 | 1.113 | 19.662 | 20.329 | 23.725 | 1.657 | 5.917 | -4.997 | 12.396 | 24.639 |
| Employees | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Neosib Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 623 | 524 | 8.045 | 8.442 | 5.382 | 2.438 | 422 | 0 | 0 | 0 |
| Current Assets | 1.158 | 1.226 | 12.854 | 13.172 | 19.525 | 596 | 5.700 | 1.309 | 14.388 | 32.066 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 250 | 75 | 381 | 0 | 3.492 | 0 |
| Cash | 1.158 | 1.226 | 12.854 | 13.172 | 19.275 | 521 | 5.319 | 1.309 | 10.896 | 32.066 |
| Shareholders Funds | 1.529 | 1.167 | 19.715 | 20.380 | 23.776 | 1.707 | 5.965 | 987 | 13.380 | 28.492 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 252 | 583 | 1.185 | 1.278 | 1.213 | 1.338 | 429 | 429 | 1.364 | 3.574 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Neosib Plus S.r.l.